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The choice of the appropriate double-strand break
(DSB) repair pathway is essential for the mainte-
nance of genomic stability. Here, we show that
the Bloom syndrome gene product, BLM, counter-
acts CtIP/MRE11-dependent long-range deletions
(>200 bp) generated by alternative end-joining
(A-EJ). BLM represses A-EJ in an epistatic manner
with 53BP1 and RIF1 and is required for ionizing-
radiation-induced 53BP1 focus assembly. Con-
versely, in the absence of 53BP1 or RIF1, BLM
promotes formation of A-EJ long deletions, consis-
tent with a role for BLM in DSB end resection. These
data highlight a dual role for BLM that influences the
DSB repair pathway choice: (1) protection against
CtIP/MRE11 long-range deletions associated with
A-EJ and (2) promotion of DNA resection. These
antagonist roles can be regulated, according to
cell-cycle stage, by interacting partners such as
53BP1 and TopIII, to avoid unscheduled resection
that might jeopardize genome integrity.
INTRODUCTION
DNA double-strand breaks (DSBs) are deleterious lesions lead-
ing to genetic rearrangements and cell death. The choice of
DSB repair pathway is an essential issue for the balance
between genome stability and diversification.
Homologous recombination (HR) and nonhomologous end-
joining (NHEJ) are two major mechanisms repairing DSBs.
Recently, an alternative end-joining (A-EJ) pathway has been
described, which has been proposed to be initiated by single-
strand DNA (ssDNA) resection at the DNA ends, driven by
MRE11 and CtIP (Guirouilh-Barbat et al., 2004; Bennardo
et al., 2008; Rass et al., 2009; Xie et al., 2009; Deriano et al.,2009). While both canonical NHEJ (C-NHEJ) and HR are neces-
sary for genomemaintenance, A-EJ is highly error-prone and is a
major source of chromosomal translocations (Boboila et al.,
2010; Guirouilh-Barbat et al., 2004; Weinstock et al., 2007; Yan
et al., 2007).
The RecQ helicase BLM has been also shown to be involved in
ssDNA resection at the initial stages of HR (Gravel et al., 2008;
Nimonkar et al., 2011). Since ssDNA resection can also lead to
A-EJ, this raises the question of whether BLMmight play a puta-
tive role in A-EJ. Conversely, BLM is required for the localization
of 53BP1 at arrested replication forks in an ATR/ATM-dependent
manner (Davalos et al., 2004; Tripathi et al., 2007). 53BP1
suppresses CtIP-mediated resection (Bouwman et al., 2010;
Bunting et al., 2010), which suggests a protective role for BLM
against A-EJ. Consistently, mutations in BLM lead to Bloom
syndrome (BS), a rare autosomal-recessive genetic disorder
associated with high levels of spontaneous sister-chromatid ex-
changes (SCEs), genome instability, and cancer predisposition
(Chu and Hickson, 2009). Thus, two apparently opposite roles
could be proposed for BLM at A-EJ initiation.
Here, we analyzed the role of BLM in A-EJ using an intrachro-
mosomal substrate that we previously showed permits the char-
acterization of A-EJ at the molecular level in a chromosomal
context (Guirouilh-Barbat et al., 2004, 2007; Rass et al., 2009).
Our data highlight a dual role for BLM in the prevention/promo-
tion of DNA end degradation and the importance of the balance
between BLM and 53BP1 in preventing deleterious DNA degra-
dation initiated by CtIP/MRE11. We propose that BLM is a
pivotal actor at an early step in DSB repair pathway choice.
RESULTS
BLMProtects against Large Deletions at A-EJ Junctions
Using the substrate depicted in Figure 1A, we previously charac-
terized the A-EJ pathway, which systematically deletes the four
30-protruding nucleotides (30-Pnt) at the junctions. In contrast,
C-NHEJ uses at least one of the four 30-Pnt (Guirouilh-Barbat
et al., 2004, 2007; Rass et al., 2009).Cell Reports 5, 21–28, October 17, 2013 ª2013 The Authors 21
Figure 1. BLM Protects against CtIP/MRE11-Dependent Long-Range Deletions and SCEs
(A) The intrachromosomal end-joining substrate. In the absence of expression of themeganuclease I-SceI,CD4 is not expressed as it is too far from the promoter.
Two I-SceI cleavage sites flank the fragment containing H2Kd. After cleavage by I-SceI, rejoining of the DNA ends leads to the excision of the internal H2Kd
fragment and the expression of CD4. These events were measured by fluorescence-activated cell sorting (FACS) and the resealed junctions were amplified by
PCR and sequenced.
(B) BLM silencing in GC92 cells. Upper panel: expression of BLM. Histograms show efficiency of total end-joining. The values correspond to five independent
experiments (p = 0.1). The error bars correspond to SEM. Lower panel: frequencies of C-NHEJ versus A-EJ.
(C) Percentage of long-range deletions (>200 bp) upon BLM silencing in combination with silencing of either CtIP or MRE11.
(legend continued on next page)
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Silencing of BLM in wild-type (WT) fibroblasts did not signifi-
cantly decrease the global end-joining efficiency (Figure 1B).
However, sequence analysis of the repair junctions revealed an
alteration of the repair pattern upon BLM silencing: a small
decrease in the frequency of 30-Pnt use, accompanied by a slight
increase in the frequency of the 30-Pnt deletion events (Figures
1B and S1). Importantly, the silencing of BLM significantly
affected the distribution of deletion sizes among deletion end-
joining events (Figure S1 and Table S1). Indeed, the frequency
of large deletions (>200 bp) was 2.8-fold increased (Figure 1C,
Figure S1, and Table S1), showing that BLM protects against
extended deletions generated by A-EJ.
BLM Protects against CtIP/MRE11-Dependent
Long-Range Deletions and SCEs
It has been proposed that A-EJ-associated deletions result from
ssDNA resection of DSB ends (Rass et al., 2009). Strikingly,
depletion of CtIP in the BLM-silenced cells totally abolished
the long deletions events normally seen in BLM-depleted cells
(Figure 1C). Moreover, silencing MRE11 also strongly decreased
long-range deletions generated by loss of BLM (Figure 1C),
consistent with the fact that CtIP acts as a cofactor of MRE11
for resection (Eid et al., 2010; Sartori et al., 2007). These data
reveal an additional role for BLM in genome stability mainte-
nance: protection against CtIP/MRE11-mediated long-range
deletions promoted by A-EJ.
A hallmark of BS cells is their high level of spontaneous SCEs.
Accordingly, silencing BLM in theWT fibroblast used here signif-
icantly increased the level of SCEs. Strikingly, whereas silencing
CtIP did not affect the frequency of SCEs in the control cells, it
partly rescued the frequency of SCEs in BLM-depleted cells (Fig-
ure 1D). Thus, CtIP is responsible in part for the high level of
spontaneous SCEs in the absence of BLM, and hence BLM pro-
tects against CtIP-induced SCEs.
53BP1, RIF1, and BLM Act in an Epistatic Manner for
Protection against A-EJ Long-Range Deletions
We next aimed at obtaining insights into the molecular mecha-
nism by which BLM represses CtIP-mediated A-EJ. The 53BP1
protein was a promising candidate, because it counteracts
resection during HR initiation and class switch recombination
(Bunting et al., 2010; Bothmer et al., 2010) and interacts with
BLM upon replication stress (Sengupta et al., 2004; Tripathi
et al., 2008).
Hence, we depleted 53BP1 in order to study its role in A-EJ
(Figure 2A). The sequence of the repair junctions showed that
silencing 53BP1 slightly reduced the frequency of 30-Pnt use
(Figure 2B). More importantly, the distribution of the deletion
sizes was also significantly affected by silencing 53BP1 (Fig-
ure 2C, Figure S2, and Table S2): the frequency of long deletions
(>200 bp) increased more than 4-fold upon silencing of 53BP1.
Silencing CtIP in 53BP1-depleted cells rescued both the fre-
quency of 30-Pnt use and the frequency of long deletions gener-(D) Impact of CtIP silencing on SCEs induced by BLM depletion in GC92 cells. Up
and quantification of SCEs (right). The horizontal lines on the scatterplot indicate t
each condition.
See also junction sequences in Table S1 and deletion distribution in Figure S1.ated by 53BP1 silencing (Figures 2B and 2C, Figure S2, and
Table S2). Interestingly, simultaneous silencing of both BLM
and 53BP1 decreased the frequency of 30-Pnt use to the level
seen with 53BP1 silencing alone (Figures 2B and Table S2) but
did not further increase the frequency of long-size deletions (Fig-
ure 2C, Figure S2, and Table S2).
RIF1, which is a partner of 53BP1 for protection against resec-
tion (Chapman et al., 2013; Di Virgilio et al., 2013; Escribano-Dı´az
et al., 2013), is required for BLM focus formation (Feng et al.,
2013). Remarkably, silencing RIF1 increased the frequency of
long-range deletions in an epistatic way with 53BP1. Moreover,
simultaneous silencing of both BLM and RIF1 did not further in-
crease the frequency of long-range deletions (Figure 2D, Fig-
ure S2, and Table S2). These data show that BLM, 53BP1, and
RIF1 act in an epistatic manner for protection against A-EJ large
deletions.
Surprisingly, while BLM protects against A-EJ long-range
deletions in WT cells, silencing BLM in cells depleted of
53BP1 or RIF1 decreased the frequency of such events
close to the frequency in cells silenced for BLM alone (Fig-
ures 2C and 2D). This suggests that BLM is involved in
generating some of the deletion events found in 53BP1- or
RIF1-depleted cells. These data reveal two opposite roles for
BLM: (1) protection against CtIP-mediated long-range dele-
tions, in association with 53BP1 and RIF1, and (2) the promo-
tion of long-range deletions, when 53BP1 or RIF1 are absent.
This second role is consistent with an involvement of BLM in
DNA end resection.
BLM Favors the Assembly of Both Radiation-Induced
53BP1 and pRPA Foci
We then addressed the question of the colocalization of
BLM and 53BP1 after ionizing radiation (IR), which efficiently
generates DSBs. Confocal analysis revealed that most of
the BLM foci colocalized with 53BP1 foci after IR (Figure 3A).
Using the proximity ligation assay (PLA), a fluorescent signal
requiring the presence of both BLM and 53BP1 was detected,
showing their close localization in situ (Figures 3B and S3A).
Moreover, coimmunoprecipitation of endogenous BLM and
53BP1 proteins was stimulated by IR. Interestingly, this
interaction was abolished by treatment with an ATM inhibitor
(Figure S3B).
Using an antibody specific for BLM phosphorylated on Thr99
(pT99BLM), which is the residue phosphorylated by ATM,
we show that pT99BLM interacted in situ with 53BP1 after IR
(Figure 3B). Moreover, pT99BLM and 53BP1 interacted in all
cell-cycle phases, but with a slight reduction in the S and G2
phases compared to the G1/S phase (Figure 3C). In contrast,
PLA analysis showed an increase (more than 2-fold) of the
IR-induced interaction of pT99BLM with its canonical partner
TopIIIa in S and G2 phases (Figure 3C). Interestingly, IR
stimulated the in situ colocalization of 53BP1 and TopIIIa in
S and G2 phases (Figure 3C). These data show that theper panel: examples of SCEs. Middle panel: expression of BLM and CtIP (left)
he median. Lower panel: number of metaphases and chromosomes counted in
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Figure 2. 53BP1, RIF1, and BLM Act in an
Epistatic Manner for Protection against
A-EJ Long-Range Deletions
(A) Silencing of 53BP1, BLM, RIF1 or CtIP in
GC92 cells.
(B) Frequencies of C-NHEJ versus A-EJ events.
(C) Percentage of long-range deletions (>200 bp)
upon 53BP1, BLM, or CtIP silencing.
(D) Percentage of long-range deletions (>200 bp)
upon RIF1, 53BP1, or BLM silencing.
See junction sequences in Table S2 and deletion
distribution in Figure S2.BLM/53BP1 interaction is favored in the G1 phase, while the
assembly of the complex with TopIIIa occurs in the S and G2
phases. The G1 phase is generally considered not to be permis-
sive for HR, which is initiated by DSB end resection, while the
S and G2 phases are. These data are thus consistent with the
fact that TopIIIa enhances BLM helicase activity, which is
required for its role in resection.
Next, we addressed the impact of BLM on IR-induced 53BP1
foci by undertaking a comparison of a BS cell line (PSNG13) with
counterparts complemented with either a WT BLM cDNA
(PSNF5) or one encoding a BLM protein mutated on residue
Thr99 (cell line PSN T99A), which is not able to be phosphory-
lated by ATM. Notably, this mutation abolishes the interaction
with 53BP1 after replication stress and fails to correct radiosen-
sitivity and chromosomal aberrations in BS cells (Beamish et al.,
2002; Davies et al., 2004; Goodarzi and Lees-Miller, 2004; Tripa-
thi et al., 2008). While BS cells were very inefficient in the assem-
bly of 53BP1 foci, complementation with WT BLM restored24 Cell Reports 5, 21–28, October 17, 2013 ª2013 The Authorsefficient 53BP1 foci formation after IR
(Figure 4A). Interestingly, the ATM phos-
phorylation mutant failed to efficiently
rescue IR-induced 53BP1 foci (Figure 4A).
These data show that BLM favors the as-
sembly of 53BP1 foci after IR in a process
requiring its phosphorylation on Thr99.
The above data raised an apparent
contradiction. On one hand, BLM is
necessary for the recruitment of 53BP1
at DSBs, where 53BP1 protects against
resection, while on the other, BLM has
been shown to promote ssDNA resection
in in vitro experiments or upon exposure
to camptothecin (Gravel et al., 2008; Ni-
monkar et al., 2011). In mammalian cells,
resection is frequently analyzed by moni-
toring phospo-RPA (pRPA) foci that label
ssDNA. Here, we show the involvement
of BLM in the assembly of pRPA foci after
IR (Figure 4B). Importantly, complemen-
tation of BS cells with T99A-BLM failed
to restore IR-induced pRPA foci. These
data suggest a role for BLM in resection
at IR-induced DSBs, which requires its
phosphorylation at Thr99. These dataare in agreement with the aforementioned association of
pT99BLM with TopIIIa in the S and G2 cell-cycle phases.
DISCUSSION
The data presented here reveal a role for BLM in genome stability
maintenance at an early step of DSB repair pathway choice: the
repression of A-EJ associatedwith long-range deletions. Indeed,
A-EJ is an error-prone pathway both at the repair junction and at
the chromosome scale (Boboila et al., 2010; Guirouilh-Barbat
et al., 2004; Simsek and Jasin, 2010; Weinstock et al., 2007;
Yan et al., 2007). In line with this, in vitro studies monitoring
plasmid ligation in BS cell crude extracts (Gaymes et al., 2002),
or ligation of episomic plasmids upon BLM ablation, showed a
decrease in the fidelity of end-joining, consistent with our data
in a chromosomal context. Moreover, it has recently been shown
that in Drosophila, the absence of BLM leads to increased chro-
mosomal instability linked to A-EJ (Garcia et al., 2011).
Figure 3. BLM’s Association with 53BP1 and TopoIIIa Is Regulated by the Cell-Cycle Phase
(A) Confocal analysis of BLM (red) and 53BP1 foci (green) colocalization in irradiated GC92 cells (5 Gy). Upper panel: representative pictures. Middle panel:
fluorescence quantification corresponding to the path indicated in the upper panel (merge). Note the correspondence of the peaks of BLM and 53BP1 fluo-
rescence. Bottom panel: quantification of the colocalization of BLM/53BP1 foci (mean ± SEM).
(legend continued on next page)
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Figure 4. BLM Favors the Assembly of Both Radiation-Induced
53BP1 and pRPA Foci
(A) Impact of BLM on 53BP1 focus assembly. Left panel: examples of
ionizing radiation (IR)-induced 53BP1 foci (5Gy) in BS cells or in BS
cells complemented with BLMwt or BLMT99A. Right panel: quantification
(mean ± SEM).
(B) Impact of BLM on pRPA focus assembly. Left panel: examples of IR-
induced pRPA foci (5Gy) in BS cells or in BS cells complemented with BLMwt
or BLMT99A. Right panel: quantification (mean ± SEM).BLM plays several roles in HR: the dissolution of Holliday junc-
tions and of abortive HR intermediates, and the promotion of
resection to facilitate initiation of HR. The two former roles are
antirecombination functions, accounting for the high level of
SCEs of BS cells. In contrast, the latter role is a prorecombination
function. This raises a paradox, because cells devoid of BLM are
not HR defective, but instead exhibit hyperrecombination phe-(B) In situ interactions between BLM or pT99 BLM with 53BP1 monitored by PLA.
or pT99 BLM/53BP1 PLA dots (mean ± SEM). See negative controls in Figure S3
(C) In situ interactions according cell cycle. Cells were arrested in G1/S with mimo
following mimosine or RO3306 treatment or 7 hr after release from amimosine arre
quantification of 53BP1/pT99 BLM PLA (left) and pT99 BLM/TopIII and 53BP1/T
26 Cell Reports 5, 21–28, October 17, 2013 ª2013 The Authorsnotypes. The data presented here help to resolve this paradox,
since they reveal a dual role for BLM: (1) protection against
CtIP/MRE11 degradation, which might constitute an additional
antirecombination role and which, at least in part, accounts for
increased SCEs in BS cells; and (2) the promotion of resection.
It is clear that resection is a double-edged sword. First, it initi-
ates HR, which is essential for maintenance of genome stability;
however, excessive initiation of HR can lead to an accumulation
of toxic HR intermediates and promote genome rearrangements
between repeat sequences. Second, resection also initiates
A-EJ events, which are error-prone and can generate profound
chromosome rearrangements. Hence, resection should be
tightly controlled to secure genome stability. Cell-cycle position
is clearly an important issue, since HR is only active in the S and
G2 phases, while C-NHEJ and A-EJ are active throughout the
cell cycle (for review, see Grabarz et al., 2012). Thus, to avoid
A-EJ, resection should be repressed in the G1 phase, when
HR is inefficient, but should be permitted in the S and G2
phases, to promote HR. The interaction of BLM and 53BP1 in
the G1 phase shown here is consistent with this protective role
against A-EJ. The interactionwith TopIIIamight then favor resec-
tion, and hence permit HR initiation in the S and G2 phases.
Indeed, the helicase activity of BLM is involved in resection
(Nimonkar et al., 2011) and the interaction of TopIIIa with BLM
enhances its helicase activity. Of note, phosphorylation at
Thr99 is required for both of the antagonist roles of BLM, and
therefore the balance between the suppression and promotion
of resection is likely to be strongly influenced by the binding of
protein partners to BLM.
Taken together, our data support a model for DSB repair in
which BLM plays a dual role at DSB repair initiation. First, the
prevention of A-EJ and long-range CtIP/MRE11-dependent
deletions, through interaction with 53BP1. In return, 53BP1 and
RIF1 restrain the intrinsic resection activity of BLM. This role
should be particularly important in the G1 phase when HR is
inactive (2)- initiation of HR via resection, which should be
restricted to the S and G2 phases. These two antagonistic roles
of BLM can be regulated by interaction with its partners, which
can modify BLM’s activities according to the position of the
cell in the cell cycle. Therefore, BLM is an essential actor in the
early stages of DSB repair pathway choice, whichmust be tightly
controlled to ensure the maintenance of genome stability.
EXPERIMENTAL PROCEDURES
DNA Manipulations
All DNA manipulations were performed as previously described previously
(Ausubel et al., 1999).
Cells and Transfections
The GC92 cell line (Rass et al., 2009) was derived from SV40-transformed
GM639 human WT fibroblasts and contains the end-joining substrate
pCOH-CD4 (Guirouilh-Barbat et al., 2004). The PSNG13 cell line is a humanLeft panels: representative pictures. Right panel: quantification of BLM/53BP1
A.
sine and in S/G2 with RO3306. Cell-cycle distributions were analyzed by FACS
st (upper left panels). Upper right panel: representative pictures. Bottom panel:
opIIIa PLA (right) in the different cell-cycle phases (mean ± SEM).
SV40-transformed BS fibroblast. PSNF5 is the PSNG13 complemented with
the wtBLM, and PSN T99A is the PSNG13 complemented with BLM mutated
on the Thr99.
GC92 cells were cultured in Dulbecco’s modified Eagle’s medium supple-
mented with 10% fetal calf serum (FCS), 2 mM glutamine, and 200 IU/ml
penicillin and incubated at 37C in 5% CO2. PSNG13, PSNF5, and PSN
T99A were cultured in minimum essential medium alpha medium supple-
mented with 10% FCS and 350 mg/ml neomycin and incubated at 37C in
5% CO2.
I-SceI was expressed by the transient transfection of the cells with the
expression plasmid pCMV-I-SceI (Liang et al., 1998). The expression of the
hemagglutinin (HA)-tagged I-SceI was verified by western blotting or immuno-
fluorescence using an anti-HA antibody (MMS-101R, Covance).
The small interfering RNA (siRNA) sequences were as follows: siBLM,
50-UUAAUUUACAGAUGUGCUCUU-30; si53BP1 (Dharmacon ‘‘Smart pool’’),
siCtIP, 50-GCUAAAACAGGAACGAAUC-30; siMRE11, 50-GAUGCCAUUGAG
GAAUAAG-30; and siRIF1: 50- GCUCUAUUGUUAGGUCCCAUUCU-30. The
siRNA complexes were incubated with the cells for 48 hr and removed prior
to I-SceI transfection, as described above.
IR was performed using a 137Cs source (2 Gy/min).
Cell Synchronization
Cells were incubated for 20 hr before analysis with Mimosin (250 mM [Sigma],
for G1/S arrest) or the inhibitor of Cdk1 RO3306 (5 mM [Calbiochel], for G2
arrest). For cells in S phase, mimosin was added to the medium overnight
and cells were analyzed 7 hr after the drug release.
Western Blotting
Protein extracts (25–50 mg) were resolved using 8% SDS-PAGE, transferred to
a nitrocellulose membrane, and probed with the following specific antibodies:
anti-BLM (Abcam #Ab2179), anti-CtIP (rabbit, courtesy of Dr. R. Baer), anti-
53BP1 (Cell Signaling Technology #4937), anti-RIF1 (Bethyl Laboratories,
#A300-569), anti-vinculin (Abcam #Ab18058), and anti-actin or anti-tubulin
(Sigma #A2066 and #T5168, respectively). Immunoreactivity was visualized
using an enhanced chemiluminescence detection kit (EZ-ECL, Biological
Industries).
Immunofluorescence and PLA Assays
The cells were seeded onto slides, treated and fixed in 2% PFA for 20 min,
washed in PBS, and permeabilized by ice-cold 70% ethanol (overnight) or
by 10 min in PBS, Triton 0.5%. The slides were then saturated with PBS,
Tween 0.05%, and BSA 2% and probed with the following antibodies: anti-
BLM, anti-53BP1 (see above), anti-BLM (Becton Dickinson #612522), anti-
Topoisomerase III (Abcam #Ab49673), and pT99BLM (rabbit, courtesy of
Dr. Y. Pommier). Foci colocalization was analyzed with Image J. The PLA
assays (Olink Bioscience) were conducted using the manufacturer’s protocol
with antibody staining as performed in the standard immunofluorescence
procedure.
Junction Sequence Analysis
Junction analyses were performed as previously described (Guirouilh-Barbat
et al., 2004; Rass et al., 2009).
SCE Assay
The SCE assay was performed according to the standard fluorescence-plus-
Giemsa procedure (Perry and Wolff, 1974), with some modifications. The cells
(GC92) were plated 24 hr prior to siRNA transfection. Twenty-four hours after
transfection, 10 mMBrdU (Sigma) was added to themedium and the cells were
grown for a further 48 hr. Colchicine (Sigma) was added during the final 2 hr to a
final concentration of 0.1 mg/ml. Metaphase spreads were captured using
bright-field microscopy (Leica DM5500) with a 1003 objective lens (HCX PL
APO, Leica).
Statistical Analysis
Statistical analyses (Mann-Whitney tests) were performed using GraphPad
Prism 3.0 (GraphPad Software).SUPPLEMENTAL INFORMATION
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